Omega Healthcare Investors (OHI) Stock Forecast, Price Target & Predictions
OHI Stock Forecast
Omega Healthcare Investors stock forecast is as follows: an average price target of $41.71 (represents a 10.26% upside from OHI’s last price of $37.83) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
OHI Price Target
The average price target for Omega Healthcare Investors (OHI) is $41.71 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $49.00 to $32.00. This represents a potential 10.26% upside from OHI's last price of $37.83.
OHI Analyst Ratings
According to 8 Wall Street analysts, Omega Healthcare Investors's rating consensus is 'Buy'. The analyst rating breakdown for OHI stock is 0 'Strong Buy' (0.00%), 6 'Buy' (75.00%), 2 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Omega Healthcare Investors Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | Nate Crossett | BNP Paribas | $49.00 | $42.53 | 15.21% | 29.53% |
| Oct 18, 2024 | Kai Klose | Berenberg Bank | $45.00 | $40.74 | 10.46% | 18.95% |
| Oct 07, 2024 | Juan Sanabria | BMO Capital | $45.00 | $39.35 | 14.36% | 18.95% |
| Sep 03, 2024 | Michael Lewis | Truist Financial | $39.00 | $39.66 | -1.67% | 3.09% |
| Aug 23, 2024 | James Feldman | Wells Fargo | $40.00 | $38.74 | 3.24% | 5.74% |
| Aug 23, 2024 | Michael Griffin | Griffin | $42.00 | $38.39 | 9.40% | 11.02% |
| Jun 25, 2024 | Michael Lewis | Truist Financial | $33.00 | $33.25 | -0.75% | -12.77% |
| Jun 21, 2024 | David Rodgers | Robert W. Baird | $32.00 | $33.00 | -3.03% | -15.41% |
| May 09, 2024 | Michael Carroll | RBC Capital | $32.00 | $30.83 | 3.80% | -15.41% |
| Apr 01, 2024 | Michael Lewis | Truist Financial | $32.00 | $31.82 | 0.57% | -15.41% |
| Feb 08, 2024 | Nate Crossett | BNP Paribas | $30.00 | $29.91 | 0.30% | -20.70% |
| Sep 08, 2023 | Vikram Malhotra | Mizuho Securities | $35.00 | $32.17 | 8.78% | -7.48% |
| Apr 26, 2022 | Barclays | $29.00 | $27.76 | 4.47% | -23.34% | |
| Sep 24, 2021 | Nicholas Yulico | Scotiabank | $35.00 | $29.46 | 18.81% | -7.48% |
| Aug 04, 2021 | Daniel Bernstein | Capital One Financial | $38.00 | $33.24 | 14.32% | 0.45% |
| Jul 15, 2021 | Jonathan Petersen | Jefferies | $41.00 | $34.60 | 18.50% | 8.38% |
The latest Omega Healthcare Investors stock forecast, released on Oct 31, 2024 by Nate Crossett from BNP Paribas, set a price target of $49.00, which represents a 15.21% increase from the stock price at the time of the forecast ($42.53), and a 29.53% increase from OHI last price ($37.83).
Omega Healthcare Investors Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 11 |
| Avg Price Target | - | $46.33 | $38.09 |
| Last Closing Price | $37.83 | $37.83 | $37.83 |
| Upside/Downside | -100.00% | 22.47% | 0.69% |
In the current month, the average price target of Omega Healthcare Investors stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Omega Healthcare Investors's last price of $37.83. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 09, 2024 | BMO Capital | Market Perform | Outperform | Upgrade |
| Oct 31, 2024 | Exane BNP Paribas | Neutral | Outperform | Upgrade |
| Oct 07, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Aug 26, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Aug 23, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Aug 23, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 09, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| May 09, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Mar 21, 2024 | Citigroup | Hold | Buy | Upgrade |
| Feb 26, 2024 | Wells Fargo | Overweight | Upgrade | |
| Feb 08, 2024 | Exane BNP Paribas | Neutral | Upgrade | |
| Dec 26, 2023 | Citigroup | Hold | Hold | Hold |
| Sep 12, 2023 | RBC Capital | Sector Perform | Initialise | |
| Sep 08, 2023 | Mizuho Securities | Buy | Upgrade | |
| Jan 09, 2023 | Credit Suisse | Underperform | Downgrade | |
| Aug 05, 2022 | Bank of America Securities | Buy | Upgrade |
Omega Healthcare Investors's last stock rating was published by BMO Capital on Dec 09, 2024. The company Upgrade its OHI rating from "Market Perform" to "Outperform".
Omega Healthcare Investors Financial Forecast
Omega Healthcare Investors Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $239.32M | $242.03M | $250.19M | $218.20M | $144.85M | $239.43M | $244.65M | $249.31M | $249.95M | $281.67M | $257.42M | $273.77M | $263.79M | $119.18M |
| Avg Forecast | $290.13M | $289.39M | $288.64M | $287.90M | $255.10M | $252.35M | $249.61M | $246.70M | $245.25M | $240.28M | $235.94M | $232.04M | $227.88M | $215.79M | $205.92M | $200.59M | $205.32M | $210.65M | $198.84M | $175.52M | $209.93M | $213.98M | $216.73M | $208.83M | $235.23M | $231.76M | $229.66M | $226.09M | $216.83M | $183.42M |
| High Forecast | $303.89M | $303.11M | $302.33M | $301.55M | $267.19M | $264.31M | $261.44M | $258.40M | $256.88M | $251.67M | $247.12M | $246.38M | $241.27M | $217.63M | $205.92M | $200.59M | $210.38M | $219.11M | $208.27M | $183.84M | $219.88M | $213.98M | $216.73M | $208.83M | $235.23M | $231.76M | $229.66M | $226.09M | $216.83M | $183.42M |
| Low Forecast | $275.94M | $275.23M | $274.53M | $273.82M | $242.62M | $240.01M | $237.40M | $234.63M | $233.25M | $228.53M | $224.40M | $218.41M | $214.01M | $213.95M | $205.92M | $200.59M | $201.61M | $206.21M | $189.12M | $166.94M | $199.66M | $213.98M | $216.73M | $208.83M | $235.23M | $231.76M | $229.66M | $226.09M | $216.83M | $183.42M |
| # Analysts | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.17% | 1.15% | 1.26% | 1.24% | 0.69% | 1.12% | 1.13% | 1.19% | 1.06% | 1.22% | 1.12% | 1.21% | 1.22% | 0.65% |
Omega Healthcare Investors's average Quarter revenue forecast for Mar 24 based on 3 analysts is $200.59M, with a low forecast of $200.59M, and a high forecast of $200.59M. OHI's average Quarter revenue forecast represents a -16.18% decrease compared to the company's last Quarter revenue of $239.32M (Dec 23).
Omega Healthcare Investors EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $193.22M | $233.10M | $212.17M | $200.46M | $63.59M | $212.73M | $219.31M | $227.07M | $177.75M | $285.00M | $230.14M | $304.31M | $203.42M | $45.78M |
| Avg Forecast | $251.19M | $250.54M | $249.90M | $249.25M | $220.86M | $218.47M | $216.10M | $213.58M | $212.33M | $208.02M | $204.27M | $200.89M | $197.29M | $186.82M | $178.28M | $173.67M | $177.75M | $182.37M | $172.15M | $151.96M | $181.75M | $186.08M | $188.47M | $171.05M | $204.55M | $201.54M | $199.72M | $156.21M | $188.56M | $159.50M |
| High Forecast | $263.09M | $262.42M | $261.74M | $261.07M | $231.33M | $228.83M | $226.34M | $223.71M | $222.39M | $217.88M | $213.95M | $213.30M | $208.88M | $188.42M | $178.28M | $173.67M | $182.14M | $189.69M | $180.31M | $159.16M | $190.36M | $186.08M | $188.47M | $205.26M | $204.55M | $201.54M | $199.72M | $187.45M | $188.56M | $159.50M |
| Low Forecast | $238.90M | $238.29M | $237.67M | $237.06M | $210.05M | $207.79M | $205.53M | $203.14M | $201.94M | $197.85M | $194.28M | $189.09M | $185.29M | $185.23M | $178.28M | $173.67M | $174.55M | $178.53M | $163.73M | $144.53M | $172.86M | $186.08M | $188.47M | $136.84M | $204.55M | $201.54M | $199.72M | $124.97M | $188.56M | $159.50M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.28% | 1.23% | 1.32% | 0.35% | 1.14% | 1.16% | 1.33% | 0.87% | 1.41% | 1.15% | 1.95% | 1.08% | 0.29% |
3 analysts predict OHI's average Quarter EBITDA for Mar 24 to be $173.67M, with a high of $173.67M and a low of $173.67M. This is -10.12% lower than Omega Healthcare Investors's previous annual EBITDA (Dec 23) of $193.22M.
Omega Healthcare Investors Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $65.98M | $98.77M | $59.86M | $35.94M | $45.58M | $102.27M | $89.47M | $189.61M | $32.74M | $138.95M | $84.52M | $159.98M | $61.40M | $-91.29M |
| Avg Forecast | - | - | - | - | $121.46M | $119.87M | $122.67M | $121.02M | $121.10M | $119.23M | $116.92M | $115.97M | $117.97M | $106.16M | $97.92M | $118.30M | $96.32M | $91.72M | $84.96M | $107.54M | $56.10M | $102.00M | $100.50M | $97.77M | $122.05M | $112.46M | $111.81M | $82.12M | $106.36M | $40.10M |
| High Forecast | - | - | - | - | $128.94M | $127.25M | $130.23M | $128.48M | $128.56M | $126.57M | $124.12M | $117.54M | $119.59M | $107.30M | $97.96M | $141.96M | $102.07M | $100.06M | $90.20M | $129.05M | $67.32M | $102.00M | $100.50M | $117.32M | $122.05M | $112.46M | $111.81M | $98.55M | $106.36M | $40.10M |
| Low Forecast | - | - | - | - | $113.74M | $112.25M | $114.87M | $113.33M | $113.40M | $111.64M | $109.48M | $114.40M | $116.36M | $105.03M | $97.87M | $94.64M | $93.44M | $88.94M | $79.56M | $86.03M | $44.88M | $102.00M | $100.50M | $78.21M | $122.05M | $112.46M | $111.81M | $65.70M | $106.36M | $40.10M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.08% | 0.70% | 0.33% | 0.81% | 1.00% | 0.89% | 1.94% | 0.27% | 1.24% | 0.76% | 1.95% | 0.58% | -2.28% |
Omega Healthcare Investors's average Quarter net income forecast for Mar 24 is $118.30M, with a range of $94.64M to $141.96M. OHI's average Quarter net income forecast represents a 79.28% increase compared to the company's last Quarter net income of $65.98M (Dec 23).
Omega Healthcare Investors SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.27M | $11.03M | $21.66M | $20.16M | $15.63M | $17.88M | $18.41M | $16.02M | $17.90M | $15.37M | $15.20M | $16.15M | $15.19M | $14.81M |
| Avg Forecast | $20.26M | $20.20M | $20.15M | $20.10M | $17.81M | $17.62M | $17.43M | $17.22M | $17.12M | $16.78M | $16.47M | $16.20M | $15.91M | $15.07M | $14.38M | $10.22M | $14.33M | $14.71M | $13.88M | $9.29M | $30.17M | $14.94M | $15.13M | $8.45M | $16.42M | $16.18M | $16.03M | $8.29M | $15.14M | $12.81M |
| High Forecast | $21.22M | $21.16M | $21.11M | $21.05M | $18.66M | $18.45M | $18.25M | $18.04M | $17.93M | $17.57M | $17.25M | $17.20M | $16.85M | $15.19M | $14.38M | $12.27M | $14.69M | $15.30M | $14.54M | $11.15M | $36.20M | $14.94M | $15.13M | $10.14M | $16.42M | $16.18M | $16.03M | $9.95M | $15.14M | $12.81M |
| Low Forecast | $19.27M | $19.22M | $19.17M | $19.12M | $16.94M | $16.76M | $16.57M | $16.38M | $16.29M | $15.96M | $15.67M | $15.25M | $14.94M | $14.94M | $14.38M | $8.18M | $14.08M | $14.40M | $13.20M | $7.43M | $24.14M | $14.94M | $15.13M | $6.76M | $16.42M | $16.18M | $16.03M | $6.63M | $15.14M | $12.81M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.65% | 0.75% | 1.56% | 2.17% | 0.52% | 1.20% | 1.22% | 1.90% | 1.09% | 0.95% | 0.95% | 1.95% | 1.00% | 1.16% |
Omega Healthcare Investors's average Quarter SG&A projection for Mar 24 is $10.22M, based on 3 Wall Street analysts, with a range of $8.18M to $12.27M. The forecast indicates a 10.24% rise compared to OHI last annual SG&A of $9.27M (Dec 23).
Omega Healthcare Investors EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.27 | $0.37 | $0.25 | $0.15 | $0.19 | $0.44 | $0.38 | $0.79 | $0.14 | $0.58 | $0.36 | $0.69 | $0.27 | $-0.40 |
| Avg Forecast | - | - | - | - | $0.44 | $0.43 | $0.45 | $0.44 | $0.44 | $0.43 | $0.42 | $0.42 | $0.43 | $0.39 | $0.36 | $0.32 | $0.35 | $0.33 | $0.31 | $0.28 | $0.55 | $0.39 | $0.38 | $0.33 | $0.47 | $0.43 | $0.43 | $0.45 | $0.41 | $0.15 |
| High Forecast | - | - | - | - | $0.47 | $0.46 | $0.47 | $0.47 | $0.47 | $0.46 | $0.45 | $0.43 | $0.43 | $0.39 | $0.36 | $0.32 | $0.37 | $0.36 | $0.33 | $0.30 | $0.59 | $0.39 | $0.38 | $0.33 | $0.47 | $0.43 | $0.43 | $0.45 | $0.41 | $0.15 |
| Low Forecast | - | - | - | - | $0.41 | $0.41 | $0.42 | $0.41 | $0.41 | $0.41 | $0.40 | $0.42 | $0.42 | $0.38 | $0.36 | $0.32 | $0.34 | $0.32 | $0.29 | $0.26 | $0.52 | $0.39 | $0.38 | $0.33 | $0.47 | $0.43 | $0.43 | $0.45 | $0.41 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 1.11% | 0.81% | 0.53% | 0.34% | 1.13% | 0.99% | 2.39% | 0.30% | 1.35% | 0.84% | 1.54% | 0.66% | -2.61% |
According to 3 Wall Street analysts, Omega Healthcare Investors's projected average Quarter EPS for Mar 24 is $0.32, with a low estimate of $0.32 and a high estimate of $0.32. This represents a 18.10% increase compared to OHI previous annual EPS of $0.27 (Dec 23).
Omega Healthcare Investors Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| GMRE | Global Medical REIT | $8.46 | $11.75 | 38.89% | Buy |
| NHI | National Health Investors | $71.77 | $85.00 | 18.43% | Hold |
| OHI | Omega Healthcare Investors | $39.34 | $41.71 | 6.02% | Buy |
| VTR | Ventas | $60.22 | $63.10 | 4.78% | Buy |
| SBRA | Sabra Health Care REIT | $17.65 | $18.00 | 1.98% | Hold |
| LTC | LTC Properties | $36.51 | $37.00 | 1.34% | Hold |
| HR | Healthcare Realty Trust | $17.51 | $17.00 | -2.91% | Buy |
| CTRE | CareTrust REIT | $28.53 | $26.50 | -7.12% | Buy |